-
November 30, 2011
Uncertainty still means discount for WellPoint.
-
November 28, 2011
Medtronic has gone from over-loved to under-loved, and value investors should take note.
-
November 25, 2011
Medtronic's stock is worth a close look.
-
October 31, 2011
Zimmer continues to trade at a very reasonable forward P/E.
-
October 25, 2011
Why is Abbott deciding to break apart?
-
October 24, 2011
St. Jude's growth is lacking, today. However, it could be a winner for the patient investor.
-
October 24, 2011
Stryker's growth is modest, but the stock potential is surprising.
-
October 21, 2011
J&J trades at a reasonable forward P/E and offers investors downside protection.
-
September 01, 2011
Learn more about four companies that have managed impressive operating cash flow amid August's unstable markets.
-
August 29, 2011
Medtronic's stock deserves a close look.
-
August 04, 2011
Another quarter brings another hope for better days at BSX.
-
July 26, 2011
St Jude continued to grow robustly during its second quarter.
-
July 26, 2011
A handful of health care peers trade at more appealing earnings multiples than Baxter.
-
July 20, 2011
JNJ's performance is mediocre, as are its investment prospects.
-
July 14, 2011
Shares of these three companies have stunningly low P/E ratios, meaning even the smallest catalyst, like good news ...
-
July 12, 2011
With healthier budgets at hospitals, robots are looking better and better.
-
June 21, 2011
The healthcare sector has grown faster than the economy and seems poised to continue to do so...
-
June 17, 2011
JNJ makes a tough and surprising, but ultimately wise, decision.
-
June 14, 2011
AngioDynamics is shaking things up in the hopes of rekindling growth.
-
June 01, 2011
These stocks have recently sparked insider interest, even despite price declines.
